Last reviewed · How we verify

Can Vitamin D Supplementation Prevent Food Allergy in Infants? The VITALITY Trial

NCT02112734 Phase 4 ACTIVE_NOT_RECRUITING

We report that Australia has the highest prevalence of Immunoglobulin(Ig)E-mediated food allergy in the world, with 10% of infants having challenge-proven food allergy in Melbourne. There has been a 5-fold increase in hospital admissions for life-threatening anaphylaxis. These changes are most pronounced in children less than 5 years, suggesting a causal role for early life determinants. We have primary data to inform hypotheses for the rise in food allergy, which appears to result from potentially modifiable factors related to the modern lifestyle, particularly Vitamin D insufficiency (VDI). We propose an intervention study to assess if infant Vitamin D supplementation during the first year of life significantly decreases the risk of early-onset food allergy and other allergic disease at 12 months (part 1) and 6 years of age (part 2). Australia is ideally placed to answer this important question since, unlike the USA, Canada and Europe, there are no population recommendations for routine infant supplementation with Vitamin D and we are one of the few developed countries that do not supplement the food chain supply with Vitamin D.

Details

Lead sponsorMurdoch Childrens Research Institute
PhasePhase 4
StatusACTIVE_NOT_RECRUITING
Enrolment2739
Start date2014-12
Completion2028-12

Conditions

Interventions

Primary outcomes

Countries

Australia